FF 
Principal Investigator/Prog ram Director (Last, first, middle). 
BIOGRAPHICAL SKETCH 
Give the following information for the key personnel and consultants and collaborators. Begin with the principal 
investigator/program director. Photocopy this page for each person. 
NAME 
Ivor Royston, M.D. 
POSITION TITLE 
President and Scientific Director 
INSTITUTION AND LOCATION 
DEGREE 
YEAR 
CONFERRED 
FIELD OF STUDY 
George Washington Univ., Washington, DC 
Johns Hopkins Univ., Baltimore, MD 
B.A. 
1967 
Pre-medicine 
Human Biology 
Johns Hopkins Univ., Baltimore, MD 
M.D. 
1970 
Medicine 
Stanford University, Stanford, CA 
1977 
Medical Oncology 
RESEARCH AND PROFESSIONAL EXPERIENCE: Concluding with present position, Rst, m chronological oroer, previous employment, experience, ana 
honors. Key personnel include the principal investigator and any other individuals who participate in the scientific development or execution of the project 
Key personnel typically will indude all individuals with doctoral or other professional degrees, but in some projects will Include individuals at the masters or 
baccalaureate level provided they contribute in a substantive way to the scientific development or execution of the project Indude present membership on 
any Federal Government public advisory committee. List In chronological order, the titles, all authors, and complete references to all pubBcations during the 
past three years and to representative earlier pubBcations pertinent to this application. DO NOT EXCEED TWO PAGES. 
Professional Experience 
1970- 71 Intern, Internal Medicine, Stanford University Hospital, Stanford, CA 
1971- 72 Resident in Internal Medicine, Stanford University Hospital, Stanford, CA 
1972- 73 Staff Associate, Division of Virology, Bureau of Biologies, NIH, Bethesda, MD 
1973- 75 Chief, Viral Oncology Section, Division of Virology, Bureau of Biologies, NIH, Bethesda, MD 
1975-77 Post-doctoral Fellow, Division of Oncology, Department of Medicine, Stanford University Schi 
of Medicine, Stanford, CA 
1977-78 Staff Physician, Veterans Administration Medical Center, San Diego, CA 
1977- 82 Assistant Professor of Medicine, Division of Hematology/Oncology, University of California, 
San Diego, School of Medicine, La Jolla, CA 
1978- 81 Clinical Investigator, Veterans Administration Medical Center, San Diego, CA 
1980- 91 Immunology & Genetics Committee, Cancer and Leukemia Group B 
1981- 91 Vice Chairman, Immunology and Genetics Committee of Cancer and Leukemia Group B 
1981-90 Director, Cell Surface Marker Laboratory, UCSD Cancer Center, San Diego 
1981- 84 Chief, Medical Oncology, San Diego Veterans Administration Medical Center, San Diego, CA 
1982- 90 Associate Professor of Medicine, Division of Hematology/Oncology, UCSD School of Medicine 
1982- 85 Consulting member of the Biological Response Modifiers Program Decision Network Committee, 
Division of Cancer Treatment, National Cancer Institute/National Institutes of Health 
1983- 88 Member, Clinical Cancer Program Project Review Committee, NCI/NIH 
1984- 90 Director, Clinical Immunology Program, UCSD Cancer Center 
1986-88 Member, UCSD Biotechnology Transfer Advisory Committee 
1986-Pres. Co-Director, International Conference on Monoclonal Antibody Immunoconjugates for Cancer 
1989- 90 Member, Long Range Planning Committee, UCSD Cancer Center 
1990- Pres. President & Scientific Director, San Diego Regional Cancer Center, San Diego, CA 
1990-Pres. Adjunct Professor of Medicine, UCSD School of Medicine, San Diego, CA 
1992-Pres. Co-Director, International Gene Therapy of Cancer Conference 
1992-Pres. Member, Department of Veterans Affairs Merit Review Board for Oncology 
1992-Pres. Member, Molecular Biology of Cancer Editorial Board 
1992-Pres. Member, American Association for Cancer Research Exhibits Committee 
1992- Pres. Chairman, Special Review Committee-Clinical Trials of Cancer with BRMs, NCI-NIH 
1993- Pres. Member, Biotechnology Advisory Committee, for Congresswoman Lynn Schenk 
PHS 398 (Rev. 9/91) (Form Page 6) Page _ * nw* IS 
Number pages aj^^vsty at the bottom throughout the appfcation. Do nof use suffixes such asfte^Ombinant DNA KeseaTCll, Volume io 
